Relationship between fetal biometry, lipid accumulation product and the trophic condition at birth
Keywords:
Fetal growth and development, fetal biometry, fetal weight, fetal development, gestational age, lipid accumulation product, trophic condition at birth, metabolically obese normal-weight phenotypeAbstract
Background: Maternal nutritional status disorders are usually related to fetal growth deviations, which can be detected by fetal biophysical parameters and identify the possible trophic condition at birth.
Objective: To determine the possible relationship between fetal biometric parameters, the birth trophic state and lipid accumulation product.
Methodology: A cross-sectional study was conducted at the Chiqui Gómez Lubian Polyclinic in Santa Clara municipality, during 2019, in a population of 253 normal-weight pregnant women who were apparently healthy at the beginning of their gestation. The non-probability sample was made up of 144 pregnant women. Study variables were: lipid accumulation product, fetal biometry and trophic condition at birth. Theoretical, empirical and statistical methods were used.
Results: In the second trimester, none of the biometric parameters matched the condition at birth as a small child, while in the large one the head and abdominal circumferences matched. In the third trimester, femoral length and abdominal circumference coincide in identifying the small one and the large one. LAP correlated with third trimester abdominal circumference and birth weight, presenting higher frequency of values in the third tertile for large births.
Conclusions: Abdominal circumference was the biometric parameter with the highest coincidence with trophic condition at birth, associated with values in the third tertile of the LAP for detecting large births, relating the metabolically obese normal weight phenotype with excessive fetal growth.Downloads
References
1. Gába A, Přidalová M. Diagnostic performance of Body Mass Index in women. Eur J Clin Nutr [Internet]. 2016 [cited 2022 Jan 7];70(8):898-903. Available from: https://www.nature.com/articles/ejcn2015211
2. De Lorenzo A, Martinoli R, Vaia F, Di Renzo L. Normal weight obese (NWO) women: an evaluation of a candidate new syndrome. Nutr Metab Cardiovasc Dis [Internet]. 2006 [cited 2022 Jan 7];16(8):513-23. Available from: https://www.sciencedirect.com/science/article/abs/pii/S0939475305001912?via%3Dihub
3. Ahmadi F, Moukhah S, Hosseini R, Maghari A. Ultrasound Evaluation of Visceral Fat Thickness for Prediction of Metabolic Syndrome in the First Trimester of Pregnancy in a Sample of Non-obese Iranian Women Oman medical journal [Internet]. 2019 [cited 2022 Jan 07];34(4):308-312. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642717/pdf/OMJ-D-18-00114.pdf
4. Du T, Yu X, Zhang J, Sun X. Lipid accumulation product and visceral adiposity index are effective markers for identifying the metabolically obese normal-weight phenotype. Acta Diabetol [Internet]. 2015 [cited 2022 Jan 07];52:855-63. Available from: https://link.springer.com/article/10.1007%2Fs00592-015-0715-2
5. Mejia Montilla J, Reyna Villasmil E. Obesidad, insulinorresistencia e hipertensión durante el embarazo. Rev Venezolana Endocrinol Metab [Internet]. 2017 [citado 20 Ene 2022];15(3):169-81. Disponible en: http://ve.scielo.org/pdf/rvdem/v15n3/art02.pdf
6. Beaumont RN, Kotecha SJ, Wood AR, Knight BA, Sebert S, McCarthy MI , et al.ICommon maternal and fetal genetic variants show expected polygenic effects on risk of small- or large-for-gestational-age (SGA or LGA), except in the smallest 3% of babies. PLoS Genet [Internet]. 2020 [cited 2022 Jan 07];16(12). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7721187/pdf/pgen.1009191.pdf
7. Águila Setién S, Breto García A, Cabezas Cruz E, Delgado Calzado JJ, Santisteban Alba S. Obstetricia y perinatología. Diagnóstico y tratamiento. La Habana: Editorial Ciencias Médicas; 2012
8. Kahn HS. The “lipid accumulation product” performs better than the body mass index fo rrecognizing cardiovascular risk:a population based comparison. BMC Cardiovascular Disorders [Internet]. 2005 [cited 2022 Jan 7];5(26). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1236917/pdf/1471-2261-5-26.pdf
9. AMM. Declaración de Helsinki. Principios éticos para las investigaciones con seres humanos. [59ª Asamblea General, Seúl, Corea Internet]. Corea: AMM; 2008 [citado 14 Feb 2022]. Disponible en: http://www.innsz.mx/opencms/contenido/investigacion/comiteEtica/helsinkihtml
10. Intriago-Rosado A, Macías-Guevara KB, De la torre Chávez J, Gómez-Vergara S. Trastornos metabólicos que complican el embarazo. Dominio de las Cienc [Internet]. 3 de agosto de 2017 [citado 14 Feb 2022];4(3 Especial):462-75. Disponible en: https://dominiodelasciencias.com/ojs/index.php/es/article/view/575
11. Álvarez-Guerra González E, Hernández Díaz D, Sarasa Muñoz NL, Barreto Fiu EE, Limas Pérez Y, Cañizares Luna O. Biometría fetal: capacidad predictiva para los nacimientos pequeños según su edad gestacional. AMC [Internet]. 2017 [citado 14 Feb 2022];21(6):112-19. Disponible en: http://scielo.sld.cu/pdf/mdc/v21n2/mdc04217.pdf
12. Álvarez-Guerra González E, Hernández Díaz D, Sarasa Muñoz NL, Barreto Fiu EE, Limas Pérez Y, Cañizares Luna O. Biometría fetal: capacidad predictiva para los nacimientos grandes para la edad gestacional. AMC [Internet]. 2017 [citado 4 Dic 2018];21(6):695-704. Disponible en: http://scielo.sld.cu/pdf/amc/v21n6/amc030617.pdf
13. Deter R, Lee W, Yeo L, Erez O, Ramamurthy U, Naik M, et al. Individualized growth assessment: conceptual framework and practical implementation for the evaluation of fetal growth and neonatal growth outcome. Am J Obstet Gynecol [Internet]. 2018 [cited 2022 Feb 14];218(2S):656-678. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882201/pdf/nihms930568.pdf
14. Papageorghiou AT, Kennedy SH, Salomon LJ, Altman DG, Ohuma EO, Stones W, et al. The INTERGROWTH-21st fetal growth standards: toward the global integration of pregnancy and pediatric care. Am J Obstet Gynecol [Internet]. 2018 [cited 2022 Jan 07];218(2S):630-40. Available from: https://www.sciencedirect.com/science/article/abs/pii/S0002937818300127?via%3Dihub
15. Zaliunas B, Drasutiene G, Utkus A, Kurmanavicius J. Fetal biometry: Relevance in obstetrical practice. Medicina [Internet]. 2017 [cited 2022 Feb 14];53(6):357-364. Available from: https://res.mdpi.com/medicina/medicina-53-00357/article_deploy/medicina-53-00357.pdf?filename=&attachment=1
16. Orozco Muñoz C, Cañizares Luna O, Sarasa Muñoz NL. Estado nutricional, acumulación de tejido adiposo y vulnerabilidad cardiometabólica en gestantes sanas de peso adecuado. Gac Méd Espirit [Internet]. 2018 [citado 14 Feb 2022];20(2):40-7. Disponible en: http://scielo.sld.cu/pdf/gme/v20n2/1608-8921-gme-20-02-40.pdf
17. Oliveros E, Somers VK, Sochor O, Goel K, Lopez-Jimenez F. The concept of normal weight obesity. Prog Cardio Vasc Dis [Internet]. 2014 [cited 2022 Feb 14];56(4):426-33. Available from: https://www.sciencedirect.com/science/article/pii/S003306201300176X
18. Sabino Pinho C, da Silva Diniz A. Predictive models for estimating visceral fat: the contribution from anthropometric parameters. PloS One [Internet]. 2017 [cited 2022 Feb 14];12(7). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524411/pdf/pone.0178958.pdf
19. Schaefer Graf UM, Kulbacka I, Kjos SL, Dudenhauser J, Vetter K, Herrera E. Maternal lipids as strong determinants of fetal environment and growth in pregnancies with gestational diabetes mellitus. Diabetes Care [Internet]. 2008 [cited 2022 Feb 14];31(9):1858-63. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2518359/pdf/1858.pdf
20. Hernández Díaz Y, Álvarez-Guerra González E, Hernández Díaz D, Sarasa Muñoz NL, Limas Pérez Y, Cañizares Luna O. Componentes de constitución corporal materna relacionados con nacimientos grandes para la edad gestacional. Medicentro [Internet]. 2018 [citado 7 Ene 2022];22(2):116-27. Disponible en: http://scielo.sld.cu/pdf/mdc/v22n2/mdc03218.pdf
Downloads
Published
How to Cite
Issue
Section
License
La revista GME tiene Acceso Abierto (Open Access) a su contenido bajo las premisas de que el libre acceso mejora el sistema de comunicación científica, lo cual elimina cualquier barrera que impida el acceso a la información y de que el mismo autor es el máximo beneficiario de este movimiento, al proporcionarle ventajas tanto en su aspecto económico, científico, como en servicios de valor añadido.
Los autores conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra; podrán establecer acuerdos adicionales para la distribución no exclusiva de la versión de la obra publicada en la revista, con el reconocimiento de haber sido publicado primero en esta revista.
Todo el contenido de esta revista se encuentra en Acceso Abierto, distribuido según los términos de la licencia Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) que permite el uso, distribución y reproducción no comerciales y sin restricciones en cualquier medio, siempre que sea debidamente citada la fuente primaria de publicación.